Patents for C07C 50 - Quinones (2,441)
07/2005
07/27/2005EP1556325A1 Anthraquinone quencher dyes, their methods of preparation and use
07/20/2005EP1555313A2 Method for the identification of hydroxyphenylpyruvate dioxygenase inhibitors
07/20/2005EP1185493B1 Quinones for treatment of diseases
07/14/2005WO2005042445A3 Fluorinated pentacene derivatives and processes for producing these
07/13/2005CN1638168A Quadribasic phthalocyanine copper film with controllably doped tetrachlorobenzoquinone/triphenyl phosphorus and its prepn process
07/13/2005CN1636453A Use of naphtoquinone compounds for the preparation of biocidal compositions and derivative composition
07/07/2005US20050148675 Efficient and inexpensive method to prepare ubiquinone precursors using benzenoid precursor with retention of the double bond stereochemistry; industrial scale; carbolumination of alkynes
07/07/2005DE10355358A1 Mixtures for use in organic electronic devices of simplified layer structure comprise matrix materials (some of which in e.g. (hetero)aromatic ketone form are new) and emitters containing an element of atomic number above 20
07/06/2005CN1634840A Method for synthesizing Q#-[10] by side chain coupling extension method
06/2005
06/30/2005US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
06/23/2005WO2005056812A2 Practical, cost-effective synthesis of ubiquinones
06/23/2005US20050137410 A 1-alkyl, 3,4-dialkyloxy, 5-protected hydroxy, 6-leaving group-methylbenzene, chemical intermediate; efficient and simplified synthesis of Coenzyme Q10 by reacting a metal complex of a hydrocarbon of n number of isoprenyl groups with a quinone analogue of the benzene compound describd above
06/23/2005DE10137401B4 Synthese von TMBQ mit Übergangsmetall beinhaltendem Molekularsieb als Katalysator Synthesis of TMBQ beinhaltendem with transition metal molecular sieve catalyst
06/23/2005CA2548250A1 Practical, cost-effective synthesis of ubiquinones
06/22/2005CN1629119A Process for preparing alkannin or isoalkannin
06/22/2005CN1629118A Process for oxidation preparation of 1, 4-naphthoquinone in solid phase oxidation tower by naphthalene method
06/15/2005CN1628088A Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
06/09/2005WO2004093207A3 Mixtures of matrix materials and organic semiconductors capable of emission, use of the same and electronic components containing said mixtures
06/07/2005US6903076 Antihelminthic anthraquinones and method of use thereof
05/2005
05/26/2005US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
05/25/2005EP1259231B1 Naphthoquinone derivatives as cd45 inhibitors
05/25/2005CN1618783A Preparation method of multisubstituted benzoquinone
05/19/2005US20050107472 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles
05/12/2005WO2005042445A2 Fluorinated pentacene derivatives and processes for producing these
05/11/2005CN1200699C Anthracyclinone derivatives and their use in amyloidosis
05/04/2005CN1199932C Trijunganone and its derivative, and its preparing process and application
05/04/2005CN1199931C Naphthalene alizarine derivatives, preparing method and use thereof
04/2005
04/28/2005US20050089954 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening
04/21/2005WO2005035477A1 Method of stabilizing compound having quinone skeleton and stabilized composition
04/21/2005US20050085644 Antidiabetic agents; insulin resistance
04/20/2005CN1607199A Preparation technology of L-alkannin
04/14/2005WO2005034172A2 Material and cell structure for memory applications
04/05/2005US6875746 Anticancer anthraquinones and method of use thereof
03/2005
03/30/2005CN1194956C Treating medicine for kidney hypofuction
03/24/2005CA2530510A1 Improved delivery by labile hydrophobic modification of drugs
03/23/2005CN1193974C Method for catalystically producing organic substances by partial oxidation
03/16/2005CN1594261A Preparation method of high purity physcion and chrysophanol
03/16/2005CN1594260A Process for purifying coenzyme Q10 intermediate
03/16/2005CN1193001C Separation preparing method for aloe-emodin and parietic acid
03/16/2005CN1192768C Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
03/09/2005CN1592729A Process for preparing pentacene derivatives
03/01/2005US6861447 Method for producing a coenzyme Q10/γ-cyclodextrin complex
02/2005
02/08/2005US6852895 Oxidation of a phenol compound
01/2005
01/26/2005CN1569793A Pterocarya stenoptera quinone, its preparation and use
01/20/2005US20050011012 Microbiocides; antistatic agents; softening; waterproofing; fireproofing; radiation resistance; chemical resistance; concurrent dyeing, finishing
01/13/2005US20050010060 Novel quinones as disease therapies
01/13/2005US20050009924 1,4-, 1,5- and 1,8-difunctionalized anthraquinones, useful for treating abnormal proliferation including cancer, for enhancing an anti-oxidation effect, human telomerase activity, and tissue engineering application, and for stem cell research
01/13/2005DE10328667A1 Verwendung von Benzochinonen in Mitteln zur oxidativen Behandlung von Haaren sowie Verfahren zur dauerhaften Haarverformung und Mittel Use of benzoquinones in agents for oxidative treatment of hair and method for permanent hair shaping and means
01/12/2005EP1494998A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient
01/06/2005WO2005000259A1 Use of benzoquinones in substances for the oxidative treatment of hair and method and substances for permanent hair reshaping
01/04/2005US6838443 Parasiticides
12/2004
12/29/2004EP1194137B1 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
12/29/2004CN1181855C Preparing method of hypericum perforatum extract
12/29/2004CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient
12/28/2004US6835755 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
12/22/2004EP1080066A4 Bioreductive cytotoxic agents
12/22/2004CN1556087A Preparation method of high purity alkannaphtha quinone
12/22/2004CN1181030C Process for fully synthesizing shaerweixin as novel antineoplastic
12/09/2004US20040244713 Method for treating animals or masses of water with compositions comprising quinone compounds
12/08/2004CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004CN1552708A Three compounds from traditional Chinese medicine
12/08/2004CN1178890C Method for extracting hypericin from hypericum perforatum
12/07/2004US6828450 Triptycene analogs
12/07/2004US6828347 Anti-viral multi-quinone compounds and regiospecific synthesis thereof
11/2004
11/25/2004US20040235870 Protein kinase inhibitors
11/25/2004US20040232089 Adding menadione nicotinamide bisulphite, menadione dimethylpyrimidinole bisulphite, menadione nicotinic acid bisulphite, menadione adenine bisulphite, menadione triptophane bisulphite, menadione histidine bisulphite, menadione para-aminobenzoic acid bisulphite to the water for elimination or prevention
11/24/2004EP1479295A1 Use of naphtoquinone compounds for the preparation of biocidal compositions
11/24/2004CN1176894C Process for purifying hypericin
11/24/2004CN1176893C Extracting and purifying method for hypericum perforatum component in plant
11/23/2004US6822003 The aldose reductase inhibitor is 2, 6-dihydroxy- 8-hexoxy-1,4-naphthaquinone
11/17/2004CN1546451A Hydroxyanthraquinone derivatives and their application in preparation of anticancer medicines
11/17/2004CN1546450A Alkannin derivatives as immune inhibitors and metal complexes thereof
11/11/2004WO2004096742A1 Hydroanthracene based compounds as anticancer agents
11/11/2004WO2004073699A8 Pharmaceuticals comprising shikonins as active constituent
11/11/2004CA2523019A1 Hydroanthracene based compounds as anticancer agents
11/10/2004CN1544408A 2,3-dimethoxy-5-methyl-1,4-benzoquinone ú¿ó±ú®preparation method
11/04/2004US20040220197 Hydroanthracene based compounds as anticancer agents
11/04/2004DE10317556A1 Mixtures for use in organic electronic devices of simplified layer structure comprise matrix materials (some of which in e.g. (hetero)aromatic ketone form are new) and emitters containing an element of atomic number above 20
11/03/2004EP1472208A1 Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
11/03/2004CN1173918C New hydrochinone derivatives as scavengers for oxided developer
10/2004
10/28/2004WO2004093207A2 Mixtures of matrix materials and organic semiconductors capable of emission, use of the same and electronic components containing said mixtures
10/26/2004US6809206 Contacting a phenyl ester compound with a cyclic compound in the presence of a source of cyanide or fluoride to prepare acylated cyclic 1,3-dicarbonyl compounds
10/26/2004US6809176 Compounds for use in treatment of cancer
10/07/2004US20040198814 prevention , therapy of cardiovascular disorders, dyslipidemias, glucose metabolism, hypoglycemic agents; reduce fat concentration in meat; reduce cholesterol concentration in eggs
10/07/2004US20040198716 Cysteine protease inhimbitors
10/06/2004CN1169772C Extraction process of effective rhubarb component, fast released Sanhuang prepn and its prepn process
10/05/2004US6800615 Antihelminthic anthraquinones and method of use thereof
09/2004
09/30/2004WO2004083336A2 Multifunctional antimicrobial dyes
09/29/2004CN1168695C Process for purifying and separating 2,3,5-trimethyl-hydroquinone
09/23/2004DE10310145A1 New but-2-yl-1,4-benzoquinone derivatives, useful for treating viral diseases, especially human T-cell leukemia, obtained by culturing Malbranchea cinnamonea
09/22/2004CN1531520A Self-reducing anthraquinone compounds
09/16/2004DE10308632A1 Helicobacter pylori Antibiotikum Helicobacter pylori antibiotic
09/10/2004WO2004075885A1 Antibiotic against helicobacter pylori
09/09/2004US20040175314 may be incorporated into packaging materials , for example, food and beverage packaging to scavenge unwanted oxygen; to reveal leaks in packages or to indicate package damage caused by handling or tampering
09/08/2004EP1094712A4 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics
09/08/2004CN1526695A Darr reaction process of quinone derivative composition to produce free radical and its application
09/08/2004CN1165509C Gronwell naphthaquinone derivative and its application in preparing anticancer medicine
09/02/2004WO2004073699A1 Pharmaceuticals comprising shikonins as active constituent
08/2004
08/31/2004US6784322 Contacting a solid support bound aryl diazonium salt with 3,6-dichorloquinone to form solid support-bound aryl quinone derivative, contacting it with a diazonium compound to form a an intermediate, repeating, terminating with a diazonium
08/18/2004CN1521157A Protein tyrosine phosphatase 1B inhibitor para-benzoquinone compound and process for preparing the same
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 25